Breast Cancer: Biological and Clinical Progress Proceedings of the Conference of the International Association for Breast Cancer Research, St. Vincent, Aosta Valley, Italy, May 26–29, 1991

The fight against breast cancer is expected to be effectively stimulated by interdisciplinary approaches and cross-fertilization between laboratory and clinical research findings. Of major importance are therefore meetings promoting fast transfer to clinical applications of findings by basic scienti...

Full description

Bibliographic Details
Other Authors: Dogliotti, L. (Editor), Sapino, A. (Editor), Bussolati, G. (Editor)
Format: eBook
Published: New York, NY Springer US 1992, 1992
Edition:1st ed. 1992
Series:Developments in Oncology
Online Access:
Collection: Springer Book Archives -2004 - Collection details see MPG.ReNa
Table of Contents:
  • 19. Diagnostic tools and prognostic factors in human breast cancer evaluated by morphological and immunohistochemical methods
  • VII.Therapeutic Strategies in Breast Cancer Treatment
  • 20. Oestrogen-Deprivation in Breast Cancer: Clinical and Experimental Observations
  • 21. Polyamines and Growth Factors as Possible Targets for Antitumor Therapy in Breast Cancer
  • 22. New Diagnostic Methods and Treatment Modalities in Breast Cancer
  • I. Activation of Cellular Oncogenes
  • 1. The Role of Oncogenes and Onco-Suppressor Genes in Human Breast Cancer
  • 2. Expression of the MET Oncogene in Human Tumors
  • 3. c-erbB-2, a Tyrosine Kinase Growth Factor Receptor and its Role in Breast Cancer
  • 4. Mammary Morphogenesis and Oncogenes
  • II. Polypeptides and Growth Factors Expression
  • 5. Interdependence of Hormones and Growth Factors in Lobulo-Alveolar Development of the Mammary Gland and Tumorigenesis
  • 6. The Role of Estrogen Regulated Secreted Proteins for Growth Regulation of Human Breast Cancer
  • 7. The Prolactin-lnducible Protein / Gross Cystic Disease Fluid Protein (PIP/GCDFP-15): Genetic Analysis and Hormonal Regulation of Gene Expression
  • III. Mammary Epithelium and Stroma in Vivo and in Vitro
  • 8. Role of RAS Oncogene in Human Breast Cancer: an Experimental Approach
  • 9. Interactions Between Malignant and Non-Malignant Components of the Breast
  • 10. Involvement of Heparanase and Extracellular Matrix-Bound Fibroblast Growth Factor in Tumor Progression
  • IV. Hormone Responsiveness and Oral Contraceptives
  • 11. Estrogen and Progesterone Receptor Activity in Breast Cancer Cells
  • 12. Oral Contraceptives and Breast Cancer: the Scope for a Hypothesis-Oriented Approach
  • V. Risk Factors; Monitoring of Breast Cancer Progression and Regression
  • 13. Benign Breast Disease: Links to Risk of Cancer
  • 14. Proliferation Rate in Different Cell Types in Benign Breast Disease
  • 15. Aspects of Cell Mediated Immunity in Monitoring Breast Cancer
  • 16. New Approaches to the Study of Selenium’s Chemopreventive Properties
  • VI. Biological Factors of Prognosis; the Metastatic Phenotype
  • 17. Cell Kinetics as an Indicator for Prognosis and Therapy
  • 18. Cathepsin D and Breast Cancer Metastasis: Biological and ClinicalSignificance